Abstract: The present invention is directed to a dental mount for receiving and retaining a plurality of different dental ceramic blocks used in dental restoration treatments, wherein the dental mount comprises a substantially flat front face having a plurality of dental ceramic block receiving holes located thereon; each of the dental ceramic block receiving holes being dimensioned to form a retaining fit with any one of the different dental ceramic blocks. The advantage of providing a dental mount with dedicated holes for retaining any one of the dental ceramic blocks is that the dental mount can be used to comparatively present all the different types of dental ceramic blocks next to one another in an organized and graded manner so that a dentist may make quick and accurate comparisons between the different types of dental ceramic blocks. Furthermore, the dentist can quickly assess their stock levels by glancing at the dental mount.

Abstract: A system and method for providing secure access to an organization's internal directory service from external hosted services. The system includes a remote directory service configured to accept directory service queries from an application running on hosted services. The remote directory service passes the queries to a directory service proxy server inside a firewall of the organization via a secure rendezvous service. The directory service proxy server passes the queries to the internal directory service inside said firewall. Request responses from the internal directory service pass through the directory service proxy server to the remote directory service through said firewall via the secure rendezvous service. The remote directory servicer returns the response to the requesting application.

Abstract: The present invention relates to antibodies that are immunoreactive to the mammalian, and more particularly, the human B7-H3 receptor and to uses thereof, particularly in the treatment of cancer and inflammation. The invention thus particularly concerns humanized B7-H3-reactive antibodies that are capable of mediating, and more preferably enhancing the activation of the immune system against cancer cells that are associated with a variety of human cancers.

Abstract: Devices and methods for reacting carbon dioxide with ammonia to produce an ammonium bicarbonate containing product are disclosed. Further disclosed are methods and devices pertaining to the handling of ammonia, ammonium bicarbonate products, and waste products associated with that production.

Abstract: Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of CAT, and methods for screening agents that modulate CAT level or activity in vivo or in vitro.

Abstract: A technique to enforce mobile device security policy is based on a “risk profile” of the individual device, where the risk profile is fine-grained and based on the types of applications installed on the device, the services they are accessing, and the operation(s) the user granted the device authorization to perform. Thus, the approach takes into account not only the actual applications installed on the device (and those actively in use), but also the services those applications are accessing, and the scope of operations the user has granted the device authorization to perform. By combining this information to create the risk profile, a suitable security policy, including one that does not unnecessarily degrade device usability, may then be applied.

Abstract: Methods and compositions are provided for assessing, treating, and preventing diseases, especially cancer, using cancer-associated targets (“CAT”). Methods and compositions are also provided for determining or predicting the effectiveness of a treatment for these diseases or for selecting a treatment, using CAT. Methods and compositions are further provided for modulating cell function using CAT. Also provided are compositions that modulate CAT (e.g., antagonists or agonists), such as antibodies, proteins, small molecule compounds, and nucleic acid agents (e.g., RNAi and antisense agents), as well as pharmaceutical compositions thereof. Further provided are methods of screening for agents that modulate CAT, and agents identified by these screening methods.

Abstract: A virtual trusted platform module (VTPM) requests a security state from a virtual machine manager. The security state is indicative of the integrity of at least a portion of software and hardware configurations of the virtual machine manager. The VTPM then receives, from the virtual machine manager, a signed security state comprising trusted platform credentials, and communicates the security state with the authentication server. The VTPM also, based on a secret received from the authentication server, initializes a process using the secret.

Abstract: Methods and compositions are provided for assessing, treating, and preventing diseases, especially cancer, using cancer-associated targets (CAT). Methods and compositions are also provided for determining or predicting the effectiveness of a treatment for these diseases or for selecting a treatment, using CAT. Methods and compositions are further provided for modulating cell function using CAT. Also provided are compositions that modulate CAT (e.g., antagonists or agonists), such as antibodies, proteins, small molecule compounds, and nucleic acid agents (e.g., RNAi and antisense agents), as well as pharmaceutical compositions thereof. Further provided are methods of screening for agents that modulate CAT, and agents identified by these screening methods.

Abstract: A printer extracts a media sheet from a plurality of media sheets in a media supply and moves the media sheet along a media path. A plurality of sensors on the media path generate signals as the media sheet moves past the sensors, and the printer identifies a cross-process direction dimension of the media sheet with references to signals generated by the sensors. The printer identifies the dimension of the print medium without requiring media size sensors in the media supply.

Abstract: The present invention provides a laterally diffused metal oxide semiconductor (LDMOS) transistor and a method for fabricating it. The LDMOS transistor includes an n-type epitaxial layer formed on a p-type substrate, and an asymmetric conductive spacer which acts as its gate. The LDMOS transistor also includes a source and a drain region on either side of the asymmetric conductive spacer, and a channel region formed by ion-implantation on the asymmetric conductive spacer. The height of the asymmetric conductive spacer increases from the source region to the drain region. The channel region is essentially completely under the asymmetric conductive spacer and has smaller length than that of the channel region of the prior art LDMOS transistors. The LDMOS transistor of the present invention also includes a field oxide layer surrounding the active region of the transistor, and a thin dielectric layer isolating the asymmetric conductive spacer from the n-type epitaxial layer.

Abstract: Methods and compositions are provided for assessing, treating, and preventing diseases, especially cancer, using cancer-associated targets (“CAT”). Methods and compositions are also provided for determining or predicting the effectiveness of a treatment for these diseases or for selecting a treatment, using CAT. Methods and compositions are further provided for modulating cell function using CAT. Also provided are compositions that modulate CAT (e.g., antagonists or agonists), such as antibodies, proteins, small molecule compounds, and nucleic acid agents (e.g., RNAi and antisense agents), as well as pharmaceutical compositions thereof. Further provided are methods of screening for agents that modulate CAT, and agents identified by these screening methods.

Abstract: The invention provides seed treatment compositions as well as their use, methods for treating seeds, methods of protecting plants against pests and also treated seeds and plants. In one embodiment there is provided a method of treating a seed with a seed treatment composition to induce a plant resistance mechanism against one or more pests in a plant grown from said seed.

Abstract: Systems and a method for image forming systems to skip over the non-printing photoreceptor area in order to not skip a label position on a continuous print web medium. A vacuum assembly is coupled to a controller that controls different vacuum pressures at each vacuum roller therein. The vacuum rollers provide drag and drive forces to skip a seam of the photoreceptor and a residual length based on the number and size of images on the photoreceptor.

Abstract: Methods and compositions are provided for assessing, treating, and preventing diseases, especially cancer, using cancer-associated targets (CAT). Methods and compositions are also provided for determining or predicting the effectiveness of a treatment for these diseases or for selecting a treatment, using CAT. Methods and compositions are further provided for modulating cell function using CAT. Also provided are compositions that modulate CAT (e.g., antagonists or agonists), such as antibodies, proteins, small molecule compounds, and nucleic acid agents (e.g., RNAi and antisense agents), as well as pharmaceutical compositions thereof. Further provided are methods of screening for agents that modulate CAT, and agents identified by these screening methods.

Abstract: The present invention relates to antibodies and their fragments that are immunoreactive to the mammalian, and more particularly, the human B7-H3 receptor and to uses thereof, particularly in the treatment of cancer and inflammation. The invention thus particularly concerns humanized B7-H3-reactive antibodies and their immunoreactive fragments that are capable of mediating, and more preferably enhancing the activation of the immune system against cancer cells that are associated with a variety of human cancers.

Abstract: A mainshaft assembly for a gearbox includes a mainshaft (44) and drive gears (31, 36) carried for rotation about the mainshaft. First and second hubs (50, 50?) are associated with respective drive gears, each hub being operable to selectively couple or uncouple with the drive gear causing it to rotate with the hub or with respect to the hub. A drive connection mechanism (42, 64, 66) associated with each hub selectively connects the hub to the mainshaft. Upon connection of the hubs to the drive gears, the drive connection operates to connect one or other of the hubs to the mainshaft when torque is applied to the mainshaft in a first direction or an opposite direction. This enables a gear ratio to be selected by reversing the torque being handled by the gearbox.

Abstract: Methods and compositions are provided for assessing, treating, and preventing diseases, especially cancer, using cancer-associated targets (“CAT”). Methods and compositions are also provided for determining or predicting the effectiveness of a treatment for these diseases or for selecting a treatment, using CAT. Methods and compositions are further provided for modulating cell function using CAT. Also provided are compositions that modulate CAT (e.g., antagonists or agonists), such as antibodies, proteins, small molecule compounds, and nucleic acid agents (e.g., RNAi and antisense agents), as well as pharmaceutical compositions thereof. Further provided are methods of screening for agents that modulate CAT, and agents identified by these screening methods.

Abstract: The present invention relates to 12 novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human secreted proteins.

Abstract: Cluster aliasing is implemented for a cluster of a plurality of computer-based members. The aliased cluster supports secured communication with a non-member node. The cluster aliasing provides an appearance to the non-member node of a common network address for the plurality of members. In supporting the secured communication, a first of the plurality of members is assigned to process secure inbound data directed to the common network address from the non-member node, and a second, different of the plurality of members is assigned to send secure outbound data from the common network address to the non-member node.